Regulatory factors in rare disease studies
The rare disease landscape poses myriad challenges for researchers, policymakers, and CROs, particularly in navigating its intricate regulatory environment. Rare…
Partner Content
-
-
Oncology trials: Delivering precision and reliability in data management
Clinical trials for oncology are filled with data management complexities that must be carefully navigated, with challenges and solutions outlined…
-
How better protocol design can reduce white space in clinical development
From the start of Phase I to the completion of Phase III, the average clinical trial cycle has been increasing…
-
The CGT frontier: what to prioritise in the transition from clinical to commercial
Projections show a $177.46 billion market by 2034 and an 18.7% CAGR. But here's the reality check: current manufacturing capacity…
-
The next act for mRNA: pushing boundaries in cell and gene therapy
The use of mRNA in therapeutics is growing ever wider following its success in Moderna’s and BioNTech’s Covid-19 vaccine programmes.…
-
The resurgence of mesenchymal stem cell therapies
Dr. Zamilpa is the Executive Director of Biomanufacturing and Collaborative Programs at BBG Advanced Therapies, a subsidiary of BioBridge Global…
-
The changing dynamics of eClinical: Why configurability is king
Clinical trial sponsors are navigating a landscape of increasing complexity. A team of researchers recently set out to explore this…
-
Podcast: Access affordability
is is the fourth episode in our Insights Uncovered: A Real-World Data Podcast Series, exploring the evolving landscape of real-world…
-
What causes white space in early-stage drug development?
White space refers to unproductive gaps in drug development, when progress stalls due to scientific barriers or because of process,…
-
Sharp Services invests $100 million in US and European facilities to increase capacity and service offerings
Sharp Services, a leader in pharmaceutical packaging, clinical trial services and sterile manufacturing has announced a $100 million investment across its…